Genome and Epigenome Analysis of Circulating Nucleic Acid-based Liquid Biopsy (Cell-Free Epigenome) - 08.23.18

Overview | Description | Applications | Operations | Results | Publications | Imagery

ISS Science for Everyone

Science Objectives for Everyone
The Genome and Epigenome Analysis of Circulating Nucleic Acid-based Liquid Biopsy (Cell-Free Epigenome) investigation analyzes cell-free DNA and RNA molecules in blood samples collected from crew members before and during spaceflight. Chemical DNA modifications are organ-specific and indicate the status of internal organs corresponding to origin of cell-free DNA (cfDNA), and RNA content indicating gene expression; so this analysis amounts to a non-invasive, “liquid biopsy.” Results help scientists better understand genetic-level changes in the human body that occur during spaceflight.
Science Results for Everyone
Information Pending

The following content was provided by Chie Matsuda, Ph.D., and is maintained in a database by the ISS Program Science Office.
Information provided courtesy of the Japan Aerospace and Exploration Agency (JAXA).
Experiment Details

OpNom: Cell-Free Epigenome

Principal Investigator(s)
Masafumi Muratani, Ph.D., Department of Genome Biology, Faculty of Medicine , University of Tsukuba, Tsukuba, Ibaraki, Japan

Co-Investigator(s)/Collaborator(s)
Satoru Takahashi, M.D., Ph.D., Department of Genome Biology, Faculty of Medicine , University of Tsukuba, Tsukuba, Ibaraki, Japan

Developer(s)
Japan Aerospace Exploration Agency, Space Environment Utilization Center, Tsukuba, Japan

Sponsoring Space Agency
Japan Aerospace Exploration Agency (JAXA)

Sponsoring Organization
Japan Aerospace Exploration Agency

Research Benefits
Earth Benefits, Scientific Discovery

ISS Expedition Duration
September 2017 - August 2018; -

Expeditions Assigned
53/54,55/56,57/58,59/60

Previous Missions
Information Pending

^ back to top

Experiment Description

Research Overview

  • The human body works differently in space, as compared to on Earth. To understand the changes on a genetic level, it is important to analyze gene expression under spaceflight conditions.
  • The Genome and Epigenome Analysis of Circulating Nucleic Acid-based Liquid Biopsy (Cell-Free Epigenome) investigation uses a newly developed blood test method to analyze molecules called “cell-free DNA (cfDNA) and circulating RNA”, which are released from cells inside the body. Chemical modifications of DNA can reflect cellular status of internal organs corresponding to origin of cfDNA, while RNA contents indicates gene expression. By combining information from DNA and RNA, scientists can estimate genetic events in various tissues without direct access to these organs.
  • This study may provide important clues about genetic and cellular processes that play important roles in adaptation of the human body to the space environment. Such information is useful for developing advanced methods to accurately measure health of astronauts.

Description

Unlike conventional bulk DNA profiling from blood, which mainly observes blood cells, cell-free DNA (cfDNA) and circulating RNA (cRNA) profiling detects the cellular status of internal body without invasive operation. This is because cfDNA and cRNA represent genetic and epigenetic information released from cells in tissue. When cells are damaged or targeted by the immune system, the original cellular DNA and RNA are thought to be released into circulating blood flow. Therefore, cfDNA and cRNA profiling can be used as “liquid biopsy” to assess cellular status and integrity of tissue inside the body.
 
The Genome and Epigenome Analysis of Circulating Nucleic Acid-based Liquid Biopsy (Cell-Free Epigenome) investigation compares the cfDNA and cRNA profile among samples collected on Earth and during spaceflight. The results should provide key information including (i) low-frequency gene mutation events in internal tissue cells, (ii) cellular origin of cfDNA which represents sites of cellular damage or excessive tissue turnover by alteration of stem cell activity or cell death, and (iii) cRNA expression profile to screen gene-specific biomarker of stress response.
 
Direct sequencing of cfDNA by ultra-high throughput sequencing could detect mutations in DNA. When combined with advanced methods to reduce sequencing error, DNA mutations detected by sequencing can be a reliable indicator of genetic damage by space radiation in the human body under normal DNA repair function.
 
The Research Team also performs detection and quantification of epigenetic modification (methylation) of cfDNA. Since the methylation pattern of DNA is specific for cell types, this information can be used to identify the cellular origins of cfDNA. The cRNA expression profile indicates cellular pathways that respond against environmental stress. If there are any genes specifically up or downregulated during flight, these genes could be important to enhance environmental tolerance. Such genes may be targets for drug development, or specific biomarker candidates.

^ back to top

Applications

Space Applications
Better methods of detecting stress biomarkers – measurable, specific characteristics – in astronauts living and working in the space environment advances crew health monitoring and countermeasure development. Comparing human data from this study with previous mouse project data adds to a better understanding of mammalian response to the space environment, and may lead to identification of genetic changes useful as biomarkers.

Earth Applications
Results also contribute to understanding how cells work to maintain bodily functions on Earth. This supports development of medical treatments for issues associated with aging, and understanding of biological responses to radiation and microgravity exposure, that cause aging-related symptoms.

^ back to top

Operations

Operational Requirements and Protocols

Cold Stowage requirement: Blood tubes are stored in the Minus-Eighty Freezer for ISS (MELFI) until return to Earth.
  • Blood drawings of 5 ml are performed 3 times during preflight, 4 times in flight, and 4 times during postflight for plasma sampling.
  • The blood tubes are centrifuged, then, stored at -80°C.
  • One extra vial of 5 ml blood is collected for genome sequencing at first pre-BDC. It is inverted and frozen at -80°C.

^ back to top

Decadal Survey Recommendations

Information Pending

^ back to top

Results/More Information

Information Pending

^ back to top

Related Websites
Information on Cell Free Epigenome from the 2014 call for International public recruitment for life science themes for the International Space Station in the space medicine field (In Japanese)

^ back to top


Imagery